Status:
WITHDRAWN
Interruptions in the Coagulationsystem in Relation With Cardiac Surgery - A Study Comparing Two Heparinization Strategies During On-pump Cardiac Surgery
Lead Sponsor:
Aalborg University Hospital
Collaborating Sponsors:
Medtronic
Conditions:
Cardiac Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to find the heparinization method, which 1. affect the heparin-protaminsulfate ratio in the best way to achieve haemostasis 2. gives the smallest change in endogenous thr...
Eligibility Criteria
Inclusion
- Elective on-pump coronary artery bypass grafting (CABG) single procedure
- Elective aortavalve replacement (AVR) (single procedure)
Exclusion
- Emergency procedures
- Children and youngsters less than 18 years
- Pregnancy
- Less than 2 days break with platelet inhibiting drugs (acetylsalicylic acid, NSAID, clopidogrel, serotonin reuptake inhibitors)
- Less than 2 days break with AC-treatment (warfarin, heparin, coumarin etc)
- Known coagulopathy
- Endocarditis
- Preoperative anaemia
- Dialysis patients
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01462968
Start Date
November 1 2011
End Date
March 1 2012
Last Update
June 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg Hospital
Aalborg, Aalborg, Denmark, 9000